dna

Featured Market Report: Gene Therapies Outlook

pharmafile | October 13, 2015 | Feature | Manufacturing and Production, Research and Development  

This report provides a comprehensive view of the clinical, R&D, commercial and competitive landscape of gene therapy, and assesses key developments in delivery vector technology, and challenges and advances associated with the production of such vectors.

GBI Research’s report discusses all gene therapies under the broad criteria of genetic material introduced to the cell, and gives the reader understanding of the current status of the field of therapeutic gene therapies, and the relative clinical and commercial success of currently marketed products, comprising Glybera, Kynamro, Macugen, Vitravene, Gendicine, Oncorine, and Neovasculgen.

It also gives valuable insight into the gene therapies pipeline, categorised by therapy area, vector type and intervention type, and stage of development, as well as a clear picture of the current competitive landscape and involvement of leading pharmaceutical companies. 

Read a description and purchase the report here. 

Related Content

No items found
The Gateway to Local Adoption Series

Latest content